Inventor · disambiguated record
Deepank Utkhede
Also filed as: UTKHEDE DEEPANK · UTKHEDE JR DEEPANK
8 granted patents·14 pending applications·27 citations·filing 2008–2022
83Inventor score
Files withMATI THERAPEUTICS INC16QLT PLUG DELIVERY INC2CADDEN SUZANNE1MORRIS JEROME A1QLT PLUG DELIVERY INC QPDI1
Top patents by PatentIndex Score
22 records- 0192US10603274B2Ophthalmic drug sustained release formulation and uses thereofMATI THERAPEUTICS INC·Filed 2017·Granted Mar 31, 2020·13 cites·20 claims
- 0288US11324693B2Ophthalmic drug sustained release formulation and uses thereofMATI THERAPEUTICS INC·Filed 2020·Granted May 10, 2022·2 cites·20 claims
- 0381US9610271B2Sustained release delivery of active agents to treat glaucoma and ocular hypertensionMATI THERAPEUTICS INC·Filed 2013·Granted Apr 4, 2017·5 cites·20 claims
- 0471US10632012B2Sustained release delivery of active agents to treat glaucoma and ocular hypertensionMATI THERAPEUTICS INC·Filed 2017·Granted Apr 28, 2020·2 cites·30 claims
- 0570US11957784B2Ophthalmic drug sustained release formulation and uses thereofMATI THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·0 cites·20 claims
- 0667US9974685B2Drug delivery system and methods of treating open angle glaucoma and ocular hypertensionMATI THERAPEUTICS INC·Filed 2013·Granted May 22, 2018·4 cites·20 claims
- 0767US8628792B2Drug cores for sustained release of therapeutic agentsUTKHEDE DEEPANK·Filed 2012·Granted Jan 14, 2014·1 cites·27 claims
- 0864US2009104243A1Drug cores for sustained release of therapeutic agentsQLT PLUG DELIVERY INC QPDI·Filed 2008·Application pending·0 cites
- 0963US2019105265A1Drug cores for sustained release of therapeutic agentsMATI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1062US2020323685A1Sustained release delivery of active agents to treat glaucoma and ocular hypertensionMATI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1162US2022331160A1Static pin insertion tool for lacrimal implantMATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1261US2014186420A1Drug cores for sustained release of therapeutic agentsMATI THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1360US2015064230A1Sustained release delivery of one or more agentsMATI THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1459US2017304194A1Drug cores for sustained release of therapeutic agentsMATI THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1556US2019091066A1Drug Delivery System and Methods of Treating Open Angle Glaucoma and Ocular HypertensionMATI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1654US11406532B2Static pin insertion tool for lacrimal implantMATI THERAPEUTICS INC·Filed 2017·Granted Aug 9, 2022·0 cites·36 claims
- 1753US2013053794A1Sustained release delivery of active agents to treat glaucoma and ocular hypertensionCADDEN SUZANNE·Filed 2012·Application pending·0 cites
- 1849US2010189766A1Substance delivering punctum implants and methodsQLT PLUG DELIVERY INC·Filed 2009·Application pending·0 cites
- 1948US2010209477A1Sustained release delivery of one or more agentsQLT PLUG DELIVERY INC·Filed 2010·Application pending·0 cites
- 2047US2021023165A1Ophthalmic drug sustained release formulation and uses for dry eye syndrome treatmentMATI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2140US2015133546A1Sustained release delivery of one or more agentsMATI THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2237US2013289089A1Pharmaceutical Compositions for Topical Delivery of Photosensitizers and Uses ThereofMORRIS JEROME A·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →